HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Safety Review Requested For Nano Silicas; Angel Dream; More

This article was originally published in The Rose Sheet

Executive Summary

Concerns about four types of nano silicas used in cosmetic products have prompted the European Commission to request a safety assessment from its Scientific Committee on Consumer Safety. More news in brief.

You may also be interested in...



P&G Investigates Greenpeace Claims Against Palm Oil Suppliers

Procter & Gamble is launching an investigation into a report by Greenpeace claiming the firm sources palm oil from suppliers or third parties involved in deforestation in Indonesia. The Cincinnati-based firm says it takes the allegations “very seriously” and is acting upon them, while the NGO says the company has greenwashed its efforts so far and should commit to making “real guarantees” in promoting sustainability.

In Brief: NPD On Men’s Fragrance Growth; PCPC Defends Phthalates; More

PCPC maintains the safety of phthalates in cosmetics following a JAMA Pediatrics study suggesting a link to preterm birth. More news in brief.

Unilever Halts Palm Oil Purchases From Alleged Forest Destroyer

Unilever - the world's largest buyer of palm oil -has suspended its purchases from PT SMART due to allegations that the Indonesian supplier illegally destroyed areas of forest to harvest palm oil

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel